Athersys Limited and the Cell Therapy Catapult, a not-for-profit centre, which is focused on the development of the United Kingdom cell therapy industry to increase the nation's health and wealth, are pleased to announce that Athersys Limited has been awarded a grant from Innovate UK, formerly the Technology Strategy Board, which will support a Phase 2a clinical study evaluating the administration of MultiStem A cell therapy to acute respiratory distress syndrome patients. The grant is expected to provide up to approximately A 2.0 million in support over the course of the study, which will be conducted by Athersys Limited at leading clinical sites in the UK in conjunction with the Cell Therapy Catapult.
http://ift.tt/1E640Ve
http://ift.tt/1E640Ve
No comments:
Post a Comment